FDA Adverse Event Malfunction Summary report: N

VENTANA PD-L1 (SP142) ASSAY

MDR report key: 16690134 · Received April 6, 2023

Report

Report Number
2028492-2023-00026
Event Type
Malfunction
Date Received
April 6, 2023
Date of Event
March 16, 2023
Report Date
April 6, 2023
Manufacturer
VENTANA MEDICAL SYSTEMS INC
Product Code
PLS
PMA / PMN Number
P160002
Removal / Correction Number
RES91199
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

IN THIS CASE, THE REAGENT LOT NUMBER WAS NOT PROVIDED, HOWEVER, ROCHE OBSERVED UNACCEPTABLE, LIGHT STAINING WITH SOME VENTANA PD-L1 (SP142) ON-MARKET LOTS, DURING INTERNAL COMPARISON STUDIES. LIGHT STAINING AFFECTS THE BORDERLINE OF POSITIVE VERSUS NEGATIVE TEST RESULTS. AN ON-GOING INVESTIGATION HAS DETERMINED THE ROOT CAUSE IS RELATED TO VARIABILITY IN THE SELECTION OF ANTIBODY CONCENTRATION IN RAW MATERIALS, AFFECTING SPECIFIC VENTANA PD-L1 (SP142) ASSAY LOTS MADE WITH THE IMPACTED RAW MATERIALS. A NOTIFICATION HAS BEEN SENT TO US CUSTOMERS INFORMING THEM OF THE ISSUE TO IMMEDIATELY DISCONTINUE THE USE OF AND DISCARD ANY REMAINING INVENTORY OF SPECIFIC IMPACTED LOTS AND INFORMING OF AN UPDATED DATE OF EXPIRATION FOR CERTAIN LOTS.

Description of Event or Problem · 0

A CUSTOMER FROM JAPAN ALLEGED DISCREPANT RESULTS WITH THE VENTANA PD-L1 (SP142) ASSAY. THE ALLEGED SAMPLE INITIALLY GENERATED A NEGATIVE RESULT. DURING REPEAT TESTING, THE SAMPLE GENERATED A POSITIVE RESULT. THE RESULTS WERE REPORTED TO THE PHYSICIAN. NO HARM OR INJURY IS ALLEGED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1532252 VENTANA PD-L1 (SP142) ASSAY PROGRAMMED DEATH-LIGAND 1 (PD-L1) IVD, ANTIBODY PLS VENTANA MEDICAL SYSTEMS INC NA ASKU

Patients

Seq Age Sex Outcome Treatment
1 Unknown